Plasma B-type natriuretic peptide (BNP) in acute Puumala hantavirus infection.

Ann Med 2014 Feb 6;46(1):38-43. Epub 2014 Jan 6.

Institute of Diagnostics, Department of Medical Microbiology, University of Oulu , Oulu , Finland.

Background: Nephropathia epidemica (NE) is a haemorrhagic fever with renal syndrome (HFRS) caused by Puumala hantavirus (PUUV). Acute infection causes transient kidney injury, permeability disorder, and fluid retention, for example.

Methods: B-type natriuretic peptide (BNP) and N-terminal peptide (NT-proBNP) during NE were investigated; disease severity and development of clinical symptoms were considered.

Results: Mean concentrations were 80.2 pg/mL and 55.2 pg/mL for BNP, and 2362.5 pg/mL and 1057.0 pg/mL for NT-proBNP in males and females, respectively. Hospitalization was 6.3 versus 5.2 days (P = 0.01) and 5.9 versus 4.4 days (P = 0.01) for patients with elevated BNP (> 100 pg/mL) or NT-proBNP (> 300 pg/mL), respectively, compared to those with normal peptide concentrations. Weight change during hospitalization was -2.8 or -0.3 kg (P <0.05) in patients with elevated or normal BNP, respectively. Heart rate (r = -0.46, P = 0.001 and r = -0.37, P = 0.01), creatinine clearance (r = -0.46, P = 0.001 and r = -0.56, P = 0.000), blood haemoglobin concentration (r = -0.55, P = 0.000 and r = -0.52, P = 0.000), and C-reactive protein (r = -0.47, P = 0.001 and r = -0.36, P = 0.01) measured when the peptide samples were collected correlated with BNP and NT-proBNP, respectively. In addition, anterior chamber depth of eye and plasma BNP (r = -0.39, P < 0.05) displayed a correlation.

Conclusions: BNP and NT-proBNP levels are associated with severity of several clinical features of acute NE.

Download full-text PDF

Source
http://dx.doi.org/10.3109/07853890.2013.862960DOI Listing
February 2014
11 Reads

Publication Analysis

Top Keywords

versus days
8
days 001
8
puumala hantavirus
8
natriuretic peptide
8
peptide bnp
8
b-type natriuretic
8
pg/ml nt-probnp
8
pg/ml
6
pg/ml 552
4
802 pg/ml
4
552 pg/ml
4
pg/ml 10570
4
bnp 23625
4
concentrations 802
4
pg/ml bnp
4
23625 pg/ml
4
clinical symptoms
4
n-terminal peptide
4
peptide nt-probnp
4
bnp n-terminal
4

Similar Publications